Are physicians in primary health care able to recognize pulmonary fibrosis? by Purokivi, Minna et al.
Full Terms & Conditions of access and use can be found at
http://www.tandfonline.com/action/journalInformation?journalCode=zecr20
European Clinical Respiratory Journal
ISSN: (Print) 2001-8525 (Online) Journal homepage: http://www.tandfonline.com/loi/zecr20
Are physicians in primary health care able to
recognize pulmonary fibrosis?
Minna Purokivi, Ulla Hodgson, Marjukka Myllärniemi, Eija-Riitta Salomaa &
Riitta Kaarteenaho
To cite this article: Minna Purokivi, Ulla Hodgson, Marjukka Myllärniemi, Eija-Riitta
Salomaa & Riitta Kaarteenaho (2017) Are physicians in primary health care able to
recognize pulmonary fibrosis?, European Clinical Respiratory Journal, 4:1, 1290339, DOI:
10.1080/20018525.2017.1290339
To link to this article:  https://doi.org/10.1080/20018525.2017.1290339
© 2017 The Author(s). Published by Informa
UK Limited, trading as Taylor & Francis
Group.
Published online: 20 Feb 2017.
Submit your article to this journal 
Article views: 301
View related articles 
View Crossmark data
Are physicians in primary health care able to recognize pulmonary fibrosis?
Minna Purokivia, Ulla Hodgsonb, Marjukka Myllärniemib,c, Eija-Riitta Salomaad and Riitta Kaarteenahoa,e,f
aCenter for Medicine and Clinical Research, Division of Respiratory Medicine, Kuopio University Hospital, Kuopio, Finland; bDepartment of
Pulmonary Medicine, Heart and Lung Center, Helsinki, Finland; cDepartment of Clinical Medicine and Transplantation Laboratory and
Helsinki University Hospital, University of Helsinki, Helsinki, Finland; dUniversity of Turku, Turku, Finland; eUnit of Medicine and Clinical
Research, Pulmonary Division, University of Eastern Finland, Kuopio, Finland; fRespiratory Medicine, Internal Medicine Research Unit,
Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland
ABSTRACT
Background: The early diagnosis of idiopathic pulmonary fibrosis (IPF) has become increasingly
important due to evolving treatment options. IPF patients experience a significant delay in
receiving an accurate diagnosis, thus delayed access to tertiary care is associated with higher
mortality independently from disease severity.
Objective: The aims were to evaluate whether there had been a delay in the referral process, and
to determine whether the referring doctors had suspected IPF or other interstitial lung disease
(ILD) already during the time of referral.
Methods: Ninety-five referral letters of patients with IPF identified from the FinnishIPF registry
were evaluated with respect to time of referral, referring unit, grounds for referral, symptoms,
smoking status, occupational history, clinical examinations, co-morbidities, medication, radiolo-
gical findings and lung function.
Results: Fifty-nine percent of referral letters originated from primary public health care. The time
from symptom onset to referral was reported in 60% of cases, mean time being 1.5 (0.8–2.3) (95%
CI) years. The main reason for referral was a suspicion of interstitial lung disease (ILD) (63%);
changes in chest X-ray were one reason for referring in 53% of cases. Lung auscultation was
reported in 70% and inspiratory crackles in 52% of referral letters.
Conclusions: Primary care doctors suspected lung fibrosis early in the course of disease. Lung
auscultation and chest X-rays were the most common investigational abnormalities in the
referrals. Providing general practitioners with more information of ILDs might shorten the delay
from symptom onset to referral.
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Introduction
Idiopathic pulmonary fibrosis (IPF), the most com-
mon of the idiopathic interstitial pneumonias, is a
progressive lung disease with a survival rate compar-
able to lung cancer.[1] Though the incidence of IPF
has been rising in recent decades, it still seems to be
an under-recognized disease in public health care.
[2,3] It has been shown recently that the patients
with IPF commonly experience significant delays in
receiving an accurate diagnosis, the mean delay from
symptom onset to diagnosis being 2.2 years.[4,5]
This is of special concern, since the delayed access
to tertiary health care has been shown to be asso-
ciated with a higher mortality rate irrespective of the
disease severity.[5]
The early referral and diagnostics have become even
more important than previously since new treatment
options for IPF have become available. Today, there are
two disease progression delaying drugs, i.e. pirfenidone
and nintedanib, on the market,[6–8] but the only cura-
tive treatment for IPF is lung transplantation. The
evaluation for lung transplantation should be carried
out early in the course of the disease to guarantee a
better outcome for those suitable for this proce-
dure.[9,10]
There are several reasons why there may be a delay
in referring patients with suspicion of IPF to a tertiary
center. For example, the patients may wait for months
(or even years) before consulting their primary care
doctor due to cough and dyspnea in exertion, the
most common symptoms of IPF.[11] Secondly, the
suspicion of this rare disease may be missed by physi-
cians working in primary health care, and recognition
of its main clinical sign, velcro-like crackles in lung
auscultation, may be overlooked.[12] Thirdly, referring
to the tertiary care may be complicated by
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shortcomings in the referral letter, leading to delay in
arranging an appointment and even to inappropriate
examinations.
In general, the referral letter is an important docu-
ment; it should contain clinical background informa-
tion, data from performed diagnostic tests and specify
the purpose of the referral to the specialist in tertiary
care.[13–17] For this study, a group of senior consul-
tants from four university hospitals evaluated the con-
tents of patients’ referral letters included in the
FinnishIPF registry. These patients had been referred
to the tertiary care respiratory clinics due to a suspicion
of respiratory problems. The aims of this study were to
evaluate whether there had been a delay in the referral
process, and to determine whether the referring doc-
tors had suspected that their patient had IPF or other
interstitial lung disease (ILD) already during the time
of referral. The presence of specific findings known to
contribute to respiratory health, e.g. smoking, occupa-
tional history, co-morbidities, previous medication,
and information of performed diagnostic tests, was
also evaluated. This retrospective analysis may be help-
ful in planning future educational interventions for the
physicians working in the primary care.
Materials and methods
Study design
Referral letters of 95 subjects collected from the
FinnishIPF registry, whose IPF diagnosis had been re-
evaluated according to recent classification, were scru-
tinized by four senior consultants of respiratory med-
icine.[18,19] The subjects had been originally referred
to tertiary care due to respiratory problems, and they
had been examined in one of the following University
hospitals in Finland: Helsinki, Kuopio, Oulu or Turku.
A structural data acquisition form was utilized in data
collection.
Data acquisition form
A two-step Delphi exercise was performed prior to
devising the data acquisition form which would be
used in the evaluation of the quality of the referral
letters. Ten senior consultants of respiratory medicine
in a tertiary center were asked which details they found
to be the most important in a referral letter for a
respiratory clinic. The data acquisition form was then
modified by the present authors to focus especially on
the suspicion of ILD. The usability of the form was
tested by the authors with eight referral letters. The
collected data concerned time of referral, referring
unit/specialty, reason for referring, description of
patients’ complaint, smoking status, occupational sta-
tus, history of exposure, previous examinations (chest
X-ray, high resolution computed tomography (HRCT),
spirometry, diffusion capacity, laboratory findings,
oxygen saturation), co-morbidities, medication, and
clinical findings (auscultation of the lungs).
Ethical considerations
Helsinki University Central Hospital Ethical Committee
provided approval for this study, and it has been accepted
by the ethical committees of the above-mentioned uni-
versity hospitals. The National Institute of Health and
Welfare has given authorization for patient screening
from hospital databases. The study has been performed
in accordance with the ethical standards laid down on the
2000Declaration of Helsinki. All patients have given their
written informed consent.
Statistical analysis
IBM SPSS Statistics version 22 (NY, USA) was used in
statistical analyses. Percentages, mean (min-max) and
mean (95% confidence interval) were used to describe
the data. Paired samples t-test in comparing continuous
variables between time-points and chi-square test in com-
parison of categorical variables were utilized. Correlations
were analyzed with Spearman’s correlation coefficient.
Results
Origin of referral letters
Referral letters of 91 from 95 subjects were found from
hospital registries for data collection. The basic char-
acteristics of the subjects are described in Table 1. Most
of the referral letters had been written in public health
care by general practitioners working in health care
centers (59%) and specialists in tertiary health care
(18%). Of the referral letters 22% had arrived from
private doctors, mainly from specialist of respiratory
medicine (15%), with some from occupational health
care (2%).
Characteristics of the referral letters
The characteristics of the referral letters are shown in
Table 2. Certain variables that may be closely related to
evaluation of the origin of ILD such as smoking, occu-
pational factors, co-morbidities and medication, were
missing in 17–52% of referral letters. The number of
ever-smokers (51%) did not differ between male and
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female subjects. The patient’s overall ability to function
was described in 32% of referral letters.
Symptoms
The time from the onset of symptoms to referral had
been approximated in 60% of referral letters, mean
time being 1.5 (0.8–2.3) years. There was no gender-
related difference in the delay from symptom onset to
referral. An overall description of the symptoms was
found in 90% of referral letters, with cough (43%) and
dyspnea (46%) being the most common symptoms.
Clinical findings
The clinical status had been described in 71% of refer-
ral letters, usually very briefly. The lung auscultation
was described in 70% of referral letters and inspiratory
crackles had been detected in every second case.
Co-morbidities
The presence or absence of co-morbidities was
reported in 83% of referral letters. Thirty patients
were reported to have one or more chronic diseases.
The most common co-morbidities were arterial hyper-
tension (35%), diabetes (20%) and cardiovascular dis-
ease (27%). Three patients had gastro-esophageal reflux
disease. A previous diagnosis of COPD was reported
twice and chronic cardiac failure once.
Treatment interventions preceding referral
In 18 referral letters one or several treatment trials for
respiratory symptoms were described. The treatments
used were antibiotics (10 cases), oral corticosteroids
(one case), inhaled corticosteroids and/or long-acting
beta-agonists or long-acting muscarin receptor antago-
nist (four cases), short-acting beta-agonists (one case),
diuretics (one case), nitrates (one case), and proton
pump inhibitor (one case).
Chest X-ray and spirometry
Some comment about the chest X-ray was attached to
92% of referral letters. The referring doctor had stated
that the changes in the chest X-ray was one reason for
referring in 53% of referral letters. Twenty-six referral
letters (29%) included data of spirometry from refer-
ring unit, and in seven cases, the decreased lung func-
tion was considered as a reason for referral. The
presence of radiological changes in chest X-rays was
not associated with the reduction of lung volume.
Disease severity at the time of referral
To evaluate the disease severity in the time of referral,
the first spirometry measured in the respiratory unit of
the tertiary clinic was sought for analyses (Table 1). In
all, 42% of the patients had normal lung function.
Table 1. Characteristics of the patients with idio-
pathic pulmonary fibrosis (IPF) and distribution of
referral letters between university hospitals.
Number of subjects 91
F/M 39/52
Age# 55 (34–89)
FVC¶ 2.6 (2.1–3.0)
FVC (%predicted)¶ 73 (50–82)
FEV1
¶ 2.1 (1.7–2.5)
FEV1 (%predicted)
¶ 75 (55–95)
FEV1 /FVC (%predicted)
¶ 0.82 (73–94)
Referral letters per university hospital
Helsinki 35 (39%)
Turku 14 (15%)
Kuopio 18 (20%)
Oulu 24 (26%)
#Age (years), FEV1% from predicted, FVC% from predicted
and FEV% are expressed as mean (min–max). FEV1, FVC in
l min–1 are expressed as mean (95% confidence interval).
¶Reference values of Viljanen [20].
Table 2. Presence of key information in referral
letters.
Overall description of symptoms 82 (90 %)
Cough 34 (43 %)
Dyspnea 36 (46 %)
Sputum production 5 (6 %)
Hemoptysis 1 (1 %)
Duration of symptoms described 66 (60%)
Smoking
Mentioned in referral letter 53 (58%)
Ever-smokers 27 (51%)
Occupational history
At work during the time of referral 19 (22%)
Retired 62 (70%)
Not known 8 (8%)
Detailed information of profession
Farmer 2 (2%)
Blue collar work 27 (30%)
White collar work 15 (16%)
Information missing 47 (52%)
Co-morbidities
Presence or absence mentioned 74 (81%)
Information missing 17 (19%)
Previous medication
Presence or absence mentioned 63 (69%)
Information missing 28 (31%)
Clinical findings
Inspiratory crackles 46 (50%)
No crackles 16 (18%)
Information missing 29 (32%)
Objective tests as an attachment
Chest X-ray 84 (92%)
High resolution computer tomography (HRCT) 16 (18%)
Spirometry 26 (29%)
Diffusion capacity 4 (4%)
Oxygen saturation 3 (3%)
Laboratory tests 38 (42%)
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Forced vital capacity (FVC) was reduced mildly (65–
79% from predicted) in 34% and moderately (45–64%
from predicted) in 16% of cases.[21] The mild reduc-
tion of lung function was more common in male than
in female subjects, (20 versus 9, p = 0.024). Twenty-six
referral letters (29%) included data of spirometry from
referring unit, and therefore we conducted a compar-
ison of these values with those assessed at the first
evaluation at the tertiary center; we could detect no
evidence of significant disease progression in this sub-
group, i.e. their condition had not deteriorated due to
the delay while waiting for their visit to tertiary care
consultation.
Reason for referral to tertiary center
The suspicion of ILD in particular was mentioned in
63% of referral letters. A suspicion that there might be
some illness other than ILD was described in 16% of
referral letters. In eight cases, an occupational lung
disease was suspected. The researchers estimated in
their evaluation that the main reasons for referral
were specific symptoms in 50% of cases including
cough (25%) and/or dyspnea (34%), and radiological
findings in 23% of the cases. Inspiratory crackles as a
reason for referral were mentioned in 16% of referral
letters. The mean time from referral to the first visit in
the tertiary center was 56 days (range 0 to 216 days).
Quality score for the required minimum data
A quality score for the minimum data requirement for
a good referral letter in IPF suspicion was created. The
score consisted of five variables which could be evalu-
ated in primary care: description of smoking history,
patient’s symptoms, findings from lung auscultation,
chest X-ray picture and spirometry. Each variable pro-
duced one point for the score. In 31% of letters two of
the required variables were mentioned, in 31% three
variables, in 14% four variables but in only 6% were all
five variables found. The quality of referral letters did
not depend on their origin. The quality score did not
correlate with the disease severity defined according to
FVC, smoking history, length of the symptoms, and
delay from referral date to the first visit in primary care
or with the actual suspicion of any parenchymal lung
disease mentioned in the referral letter.
Discussion
As far as we are aware, this is the first study that has
evaluated the referral practice of IPF patients to tertiary
care through referral letters. This is of special interest,
since the early diagnosis of IPF has become more
important due to development of new, disease-specific
treatment options for this deadly condition. In the
present patient population the mean delay from symp-
tom onset to time of referral was still 1.5 years, paral-
leling the findings of previous studies.[4,5,21] Reasons
for this delay should be recognized and rectified if the
aim is to reduce IPF related mortality.
In this study, more than half of the referral letters
originated from primary health care, suggesting that
the physicians in primary health care seem to suspect
ILDs quite well. However, certain shortcomings in the
referral letters were regrettably common. The content
of the anamnesis was often inadequate. In concordance
with previous studies, a history of smoking was missing
in 58% of cases though it is one of the most important
etiological causes of chronic lung diseases.[11]
Similarly, information of the occupational history and
an evaluation of exposures during working life were
missing in more than half of the referral letters. The
referring doctor may ignore the occupational history
due to the advanced age of patient but it is crucial to
remember that some exposures may represent a health
hazard only after a long delay, e.g. asbestos.[22]
Information about previous medication is of impor-
tance when studying lung infiltrates as many pharma-
cological compounds are known to evoke changes in
lung parenchyma. Unfortunately, this information was
mostly absent, as reported also previously.[14] The
overall ability to function, which is an important factor
when planning the clinical examinations for a patient
in tertiary care, was missing in two out of every three
referral letters. The referral letter should provide a basis
for selection of further diagnostic tests, and these kinds
of shortcomings may lead to inappropriate examina-
tions that cause both inconvenience to the patient and
unnecessary expense.
The most typical symptoms of IPF in the early
stage of the disease are dyspnea and cough, as was
the case also in the present sample of patients.
[11,12,23] As reviewed recently by Lee et al. [24],
dyspnea predicts both survival and mortality of IPF
patients, whereas cough has been reported as an
independent predictor of disease progression, and
time-to-lung transplantation or death.[24,25] Both
of these symptoms are common in adults, especially
in the aging population, and therefore, their impor-
tance may be underestimated, leading to an unneces-
sary diagnostic delay. In this study population several
patients had undergone at least one treatment trial
before they were referred to tertiary care for further
investigations. In the differential diagnosis of pro-
longed cough or dyspnea of middle aged or elderly
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individuals, IPF as well as other ILDs should be
borne in mind.[26]
Clinical findings were missing from a third of the
referral letters, though auscultation of lungs is an inex-
pensive and useful diagnostic procedure available in all
primary health care units. According to the literature,
there seems to be a trend that physicians underestimate
the value of classical clinical examinations in diagnostics.
[27] It is noteworthy that inspiratory crackles can be
heard from the lower lung zones already in the early
course of IPF.[28] Though the crackles are more com-
mon in elderly patients,[29] the presence of bilateral fine
crackles should trigger a more detailed anamnesis, with
possible further investigations, such as chest X-ray and
spirometry, undertaken in the primary care.
There was considerable variation in the quality of the
reporting of investigations conducted preceding the
referral to tertiary care.[27] There were comments
about findings of the chest X-ray in almost every referral
letter of this study, and the referring doctor had named
the radiological changes as a reason for referral in every
second case. It has been reported that radiological
changes can be present in early stages of the disease,
even if the spirometry still is in normal limits.[30] The
numbers of spirometries performed in primary care were
found to be surprisingly low, although almost every
health center in Finland has the equipment and capability
to perform those tests. Previously, the quality of primary
care spirometry in Finland has been assessed as good.[31]
However, primary care doctors may need more training
on the use of spirometry in differential diagnosis of
respiratory diseases. Though the restrictive ventilation
pattern may be missing in the early stage of the disease,
the follow-up of spirometry may be valuable in assessing
the disease progression in an individual patient.
In the majority of the referral letters the presence of
co-morbidities was noted. Paralleling a recent Danish
study,[32] arterial hypertension, cardiovascular dis-
eases and diabetes were the most common co-morbid-
ities. The presence of these chronic conditions may act
as a confusing factor which could well lead to delayed
suspicion that there is a different lung disease.
In line with previous findings of larger IPF cohorts,
most of our subjects had normal or only mildly reduced
lung function at the time of admission to tertiary care.
[32,33] A slightly reduced lung function was more com-
mon among men. The current data do not reveal the
reason for this difference, which may be attributable to
the failure of the physicians to describe their patients
smoking habits in the referral letter. For only a small
subset of patients a spirometry evaluation had also been
conducted in primary care. In this subset IPF had not
deteriorated significantly during the delay from the time
of referring to the first visit to tertiary care.
In this cohort, the mean delay from the referral date
to the first visit in tertiary care was 56 days. Suspicion
of parenchymal lung disease, such as IPF, is not con-
sidered as a reason for an urgent referral either in
Finland or internationally. According to the current
national directions this patient group should be evalu-
ated within three months of referral, which was
achieved in 91% of the current cases.
According to the present results primary care gen-
eral practitioners suspected ILDs rather well.
However, in 49% of referral letters, three out of
five or even more of the key items of information
(description of smoking history, patient’s symptoms,
lung auscultation, chest X-ray finding and spirome-
try) were missing. This shows that the referring
doctors’ readiness to perform diagnostic tests, espe-
cially spirometry, has not improved in the last
10 years.[14] In addition, improvements are still
needed in the reporting of anamnesis and basic clin-
ical examinations. Education of primary care doctors
has been shown to improve quality of referral letters
and disease recognition.[34] A better interaction
between specialists and referring physicians, such as
regular meetings, would be one way to reduce the
number of inappropriate and incomplete referrals.
[16] However, simply providing guidelines does not
seem to improve the referral quality.[17] In the case
of rather rare diseases, such as IPF, the updating of
guidelines may not reach the primary care general
practitioner, who struggles with a wide range of
problems in his/her routine practice.
In conclusion, primary care physicians suspect lung
fibrosis early in the course of disease, and were able to
utilize the appropriate diagnostic procedures.
Nonetheless, shortcomings in referral letters were com-
mon. Inspiratory crackles in lung auscultation together
with prolonged dyspnea and/or cough should alert the
general practitioner to refer the patient for a consulta-
tion in tertiary care. Provision of more easy-to-under-
stand information about ILDs to the general public
might shorten the delay from symptom onset to refer-
ral, since it seems to be largely attributable to the
inability of the patients to recognize the seriousness
of these common symptoms.
Acknowledgments
The authors wish to thank Ewen MacDonald for providing
assistance with the language and Tuomas Selander, MSc, for
guidance in statistical analyses.
EUROPEAN CLINICAL RESPIRATORY JOURNAL 5
Funding
Minna Purokivi had grants supplied by Research Director of
Kuopio University Hospital, Foundation of the Finnish Anti-
Tuberculosis Association, and the Jalmari and Rauha Ahokas
Foundation. The FinnishIPF study has received grants from
the Academy of Finland, Sigrid Jusélius Foundation, Jane
and Aatos Erkko Foundation (MM).
Notes on contributors
Minna Purokivi, Ulla Hodgson, Marjukka Myllärniemi,
Eija-Riitta Salomaa and Riitta Kaarteenaho took part in
planning of the study, designing the data collection form
and data collection. Minna Purokivi had main responsibility
on statistical analyses and preparation of the first draft of the
manuscript. Minna Purokivi, Ulla Hodgson, Marjukka
Myllärniemi, Eija-Riitta Salomaa and Riitta Kaarteenaho
took all part in manuscript preparation and accepted its
final version.
References
[1] Vancheri C, Failla M, Crimi N, et al. Idiopathic pul-
monary fibrosis: a disease with similarities and links to
cancer biology. Eur Respir J. 2010;35(3):496–504.
[2] Navaratnam V, Fleming KM, West J, et al. The rising
incidence of idiopathic pulmonary fibrosis in the. U.K.
Thorax. 2011;66(6):462–467.
[3] Antoniou KM, Symvoulakis EK, Margaritopoulos GA,
et al. Early diagnosis of IPF: time for a primary-care
case-finding initiative? Lancet Respir Med. 2014;2(1):e1.
[4] Collard HR, Tino G, Noble PW, et al. Patient experi-
ences with pulmonary fibrosis. Respir Med. 2007;101
(6):1350–1354.
[5] Lamas DJ, Kawut SM, Bagiella E, et al. Delayed access
and survival in idiopathic pulmonary fibrosis: a cohort
study. Am J Respir Crit Care Med. 2011;184(7):842–847.
[6] Noble PW, Albera C, Bradford WZ, et al. Pirfenidone in
patients with idiopathic pulmonary fibrosis
(CAPACITY): two randomised trials. Lancet. 2011;377
(9779):1760–1769.
[7] King TE Jr., Bradford WZ, Castro-Bernardini S, et al. A
phase 3 trial of pirfenidone in patients with idiopathic
pulmonary fibrosis. N Engl J Med. 2014 May 29;370
(22):2083–2092.
[8] Richeldi L, Du Bois RM, Raghu G, et al. Efficacy and
safety of nintedanib in idiopathic pulmonary fibrosis. N
Engl J Med. 2014;370(22):2071–2082.
[9] Orens JB, Estenne M, Arcasoy S, et al. International
guidelines for the selection of lung transplant candi-
dates: 2006 update–a consensus report from the
Pulmonary Scientific Council of the International
Society for Heart and Lung Transplantation. J Heart
Lung Transplant. 2006;25(7):745–755.
[10] Wuyts WA, Thomeer M, Dupont LJ, et al., An algo-
rithm for referral of patients with IPF for lung trans-
plantation. Thorax. 2008;63(3):292.author reply
[11] Raghu G, Collard HR, Egan JJ, et al. An official ATS/
ERS/JRS/ALAT statement: idiopathic pulmonary
fibrosis: evidence-based guidelines for diagnosis and
management. Am J Respir Crit Care Med. 2011;183
(6):788–824.
[12] Oldham JM, Noth I. Idiopathic pulmonary fibrosis:
early detection and referral. Respir Med. 2014;108
(6):819–829.
[13] Jenkins RM. Quality of general practitioner referrals to
outpatient departments: assessment by specialists and a
general practitioner. Br J Gen Pract. 1993;43(368):111–113.
[14] Tuomisto LE, Erhola M, Kaila M, et al. The Finnish
national asthma programme: communication in asthma
care–quality assessment of asthma referral letters. J Eval
Clin Pract. 2007;13(1):50–54.
[15] O’Byrne L, Darlow C, Roberts N, et al. Smoothing the
passage of patients from primary care to specialist
respiratory opinion. Primary care respir J Gen Pract
Airways Group. 2010;19(3):248–253.
[16] Martinussen PE. Referral quality and the cooperation
between hospital physicians and general practice: the
role of physician and primary care factors. Scand J
Public Health. 2013;41(8):874–882.
[17] O’Donnell CA. Variation in GP referral rates: what can
we learn from the literature? Fam Pract. 2000 Dec;17
(6):462–471.
[18] Travis WD, Costabel U, Hansell DM, et al. An official
American Thoracic Society/European Respiratory
Society statement: Update of the international multi-
disciplinary classification of the idiopathic interstitial
pneumonias. Am J Respir Crit Care Med. 2013 Sep
15;188(6):733–748.
[19] Kaunisto J, Kelloniemi K, Sutinen E, et al. Re-evaluation
of diagnostic parameters is crucial for obtaining accu-
rate data on idiopathic pulmonary fibrosis. BMC Pulm
Med. 2015;15:92.
[20] Viljanen A, Halttunen P, Kreus K-E. Spirometric studies
in non-smoking, healthy adults. Scand J Clin Lab Invest.
1982;42:5–20.
[21] Schoenheit G, Becattelli I, Cohen AH. Living with idio-
pathic pulmonary fibrosis: an in-depth qualitative sur-
vey of European patients. Chron Respir Dis. 2011;8
(4):225–231.
[22] American Thoracic Society. Diagnosis and initial man-
agement of nonmalignant diseases related to asbestos.
Am J Respir Crit Care Med. 2004;170(6):691–715.
[23] Collard HR, Pantilat SZ. Dyspnea in interstitial lung dis-
ease. Curr Opin Support Palliat Care. 2008;2(2):100–104.
[24] Lee AS, Mira-Avendano I, Ryu JH, et al. The burden of
idiopathic pulmonary fibrosis: an unmet public health
need. Respir Med. 2014;108(7):955–967.
[25] Ryerson CJ, Abbritti M, Ley B, et al. Cough predicts
prognosis in idiopathic pulmonary fibrosis. Respirology.
2011;16(6):969–975.
[26] Morice AH, Fontana GA, Belvisi MG, et al. ERS guide-
lines on the assessment of cough. Eur Respir J. 2007;29
(6):1256–1276.
[27] Campbell B, Vanslembroek K, Whitehead E, et al. Views
of doctors on clinical correspondence: questionnaire
survey and audit of content of letters. BMJ. 2004;328
(7447):1060–1061.
[28] Cottin V, Cordier JF. Velcro crackles: the key for early
diagnosis of idiopathic pulmonary fibrosis? Eur Respir J.
2012 Sep;40(3):519–521.
6 M. PUROKIVI ET AL.
[29] Kataoka H, Matsuno O. Age-related pulmonary crackles
(rales) in asymptomatic cardiovascular patients. Ann
Fam Med. 2008;6(3):239–245.
[30] Kondoh Y, Taniguchi H, Ogura T, et al. Disease pro-
gression in idiopathic pulmonary fibrosis without pul-
monary function impairment. Respirology. 2013;18
(5):820–826.
[31] Tuomisto L, Jarvinen V, Laitinen J, et al. Asthma
Programme in Finland: the quality of primary care
spirometry is good. Primary care respir J Gen Pract
Airways Group. 2008;17(4):226–231.
[32] Hyldgaard C, Hilberg O, Bendstrup E. How does
comorbidity influence survival in idiopathic pulmonary
fibrosis? Respir Med. 2014;108(4):647–653.
[33] Du Bois RM, Weycker D, Albera C, et al. Ascertainment
of individual risk of mortality for patients with idio-
pathic pulmonary fibrosis. Am J Respir Crit Care Med.
2011 15;184(4):459–466.
[34] Tuomisto LE, Kaila M, Erhola M. Asthma pro-
gramme in Finland: comparison of adult asthma
referral letters in 1994 and 2001. Respir Med.
2007;101(3):595–600.
EUROPEAN CLINICAL RESPIRATORY JOURNAL 7
